Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma

Author(s):
Maldegem, A. van; Conley, A.P.; Rutkowski, P.; Patel, S.R.; Lugowska, I.; Desar, I.M.E.; Bovee, J.V.M.G. (0000-0003-1155-0481); Gelderblom, H.
Published
2019
Publication type
Article / Letter to editor
ChondrosarcomaUnresectableProgression-free survivalSystemic treatmentRetrospective
Date issued
2019-01-31
Language
English
Is part of
Oncologist (2019), Vol. 24, no. 1, p. 110-116
hdl
1887/119615
doi
10.1634/theoncologist.2017-0574